MORSE DANIEL E. 4
4 · Stellar Biotechnologies, Inc. · Filed Oct 12, 2018
Insider Transaction Report
Form 4
MORSE DANIEL E.
Director
Transactions
- Sale
Common Shares, without par value
2018-10-12$1.31/sh−7,047$9,260→ 20,741 total
Footnotes (1)
- [F1]The Issuer completed a 1-for-7 reverse share split of its common shares effective May 4, 2018. The amount stated reflects the post-split adjustment. Fractional shares resulting from the reverse share split were rounded to the nearest whole share.